BI-1206-01: A Phase I/IIa Study with BI-1206, an antibody to Fc gamma receptor IIB (FcgRIIB), and rituximab in patients with CD32+ B cell malignancy

  • Baikie, Gail (CoPI)
  • Stienstra, Deborah (PI)
  • Davies, Andrew A. (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/12 → 11/1/19

Funding

  • Social Sciences and Humanities Research Council of Canada: US$75,038.00

ASJC Scopus Subject Areas

  • Economics and Econometrics
  • Arts and Humanities (miscellaneous)
  • Cancer Research
  • Immunology
  • Oncology
  • Health(social science)

Access Project